Monocyte Subsets Responsible for Immunoglobulin G-Dependent Effector Functions In Vivo

Immunity

Volumn 35, Issue 6, 2011, Pages 932-944

  Biburger, Markus ^a   Aschermann, Susanne ^a   Schwab, Inessa ^a   Lux, Anja ^a   Albert, Heike ^a   Danzer, Heike ^a   Woigk, Melissa ^a   Dudziak, Diana ^b   Nimmerjahn, Falk ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; CELL FUNCTION; CELL POPULATION; EFFECTOR CELL; FEMALE; IN VIVO STUDY; INNATE IMMUNITY; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTES; IMMUNITY, INNATE; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; LYMPHOCYTE DEPLETION; MACROPHAGES; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOCYTES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECEPTORS, IGG;

EID: 84355162334     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.11.009     Document Type: Article

References (57)

1. Auffray C., Fogg D., Garfa M., Elain G., Join-Lambert O., Kayal S., Sarnacki S., Cumano A., Lauvau G., Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670.
2. Baudino L., Nimmerjahn F., Azeredo da Silveira S., Martinez-Soria E., Saito T., Carroll M., Ravetch J.V., Verbeek J.S., Izui S. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice. J. Immunol. 2008, 180:1948-1953.
3. Bevaart L., Jansen M.J., van Vugt M.J., Verbeek J.S., van de Winkel J.G., Leusen J.H. The high-affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma. Cancer Res. 2006, 66:1261-1264.
4. Biburger M., Aschermann S., Lux A., Nimmerjahn F. The role of Fcgamma receptors in murine autoimmune thrombocytopenia. Annu. Hematol. 2010, 89:S25-S30.
5. Bussel J. Treatment of immune thrombocytopenic purpura in adults. Semin. Hematol. 2006, 43:3-10.
6. Cartron G., Dacheux L., Salles G., Solal-Celigny P., Bardos P., Colombat P., Watier H. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 2002, 99:754-758.
7. Cines D.B., McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu. Rev. Med. 2005, 56:425-442.
8. Clarkson S.B., Kimberly R.P., Valinsky J.E., Witmer M.D., Bussel J.B., Nachman R.L., Unkeless J.C. Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody. J. Exp. Med. 1986, 164:474-489.
9. Coetzee L.M., Pieters H., van Wyk V., Cooper S., Roodt J., De Reys S., Badenhorst P.N. The effect of monoclonal anti-human-platelet antibodies on platelet kinetics in a baboon model: IgG subclass dependency. Thromb. Haemost. 2000, 83:148-156.
10. Cros J., Cagnard N., Woollard K., Patey N., Zhang S.Y., Senechal B., Puel A., Biswas S.K., Moshous D., Picard C., et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33:375-386.
11. Daley J.M., Thomay A.A., Connolly M.D., Reichner J.S., Albina J.E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 2008, 83:64-70.
12. Fossati-Jimack L., Ioan-Facsinay A., Reininger L., Chicheportiche Y., Watanabe N., Saito T., Hofhuis F.M., Gessner J.E., Schiller C., Schmidt R.E., et al. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J. Exp. Med. 2000, 191:1293-1302.
13. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
14. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
15. Giorgini A., Brown H.J., Lock H.R., Nimmerjahn F., Ravetch J.V., Verbeek J.S., Sacks S.H., Robson M.G. Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J. Immunol. 2008, 181:8745-8752.
16. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
17. Hamaguchi Y., Xiu Y., Komura K., Nimmerjahn F., Tedder T.F. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. J. Exp. Med. 2006, 203:743-753.
18. Hashimoto D., Miller J., Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 2011, 35:323-335.
19. Hazenbos W.L., Gessner J.E., Hofhuis F.M., Kuipers H., Meyer D., Heijnen I.A., Schmidt R.E., Sandor M., Capel P.J., Daëron M., et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity 1996, 5:181-188.
20. Heyns A.D., Lötter M.G., Badenhorst P.N., van Reenen O.R., Pieters H., Minnaar P.C., Retief F.P. Kinetics, distribution and sites of destruction of 111indium-labelled human platelets. Br. J. Haematol. 1980, 44:269-280.
21. Hirano M., Davis R.S., Fine W.D., Nakamura S., Shimizu K., Yagi H., Kato K., Stephan R.P., Cooper M.D. IgEb immune complexes activate macrophages through FcgammaRIV binding. Nat. Immunol. 2007, 8:762-771.
22. Hogarth P.M. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. 2002, 14:798-802.
23. Ioan-Facsinay A., de Kimpe S.J., Hellwig S.M., van Lent P.L., Hofhuis F.M., van Ojik H.H., Sedlik C., da Silveira S.A., Gerber J., de Jong Y.F., et al. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002, 16:391-402.
24. Jung S., Unutmaz D., Wong P., Sano G., De los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002, 17:211-220.
25. Kaneko Y., Nimmerjahn F., Madaio M.P., Ravetch J.V. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 2006, 203:789-797.
26. Kumar V., Ali S.R., Konrad S., Zwirner J., Verbeek J.S., Schmidt R.E., Gessner J.E. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. J. Clin. Invest. 2006, 116:512-520.
27. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692.
28. Mancardi D.A., Iannascoli B., Hoos S., England P., Daëron M., Bruhns P. FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation. J. Clin. Invest. 2008, 118:3738-3750.
29. Meyer D., Schiller C., Westermann J., Izui S., Hazenbos W.L., Verbeek J.S., Schmidt R.E., Gessner J.E. FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood 1998, 92:3997-4002.
30. Mizutani H., Furubayashi T., Kashiwagi H., Honda S., Take H., Kurata Y., Yonezawa T., Tarui S., Ikehara S. Effects of splenectomy on immune thrombocytopenic purpura in (NZW x BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production. Thromb. Haemost. 1992, 67:563-566.
31. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., Libby P., Weissleder R., Pittet M.J. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007, 204:3037-3047.
32. Nigrovic P.A., Binstadt B.A., Monach P.A., Johnsen A., Gurish M., Iwakura Y., Benoist C., Mathis D., Lee D.M. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc. Natl. Acad. Sci. USA 2007, 104:2325-2330.
33. Nimmerjahn F., Ravetch J.V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 2005, 310:1510-1512.
34. Nimmerjahn F., Ravetch J.V. Fcgamma receptors: old friends and new family members. Immunity 2006, 24:19-28.
35. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 2008, 8:34-47.
36. Nimmerjahn F., Bruhns P., Horiuchi K., Ravetch J.V. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity 2005, 23:41-51.
37. Nimmerjahn F., Anthony R.M., Ravetch J.V. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc. Natl. Acad. Sci. USA 2007, 104:8433-8437.
38. Nimmerjahn F., Lux A., Albert H., Woigk M., Lehmann C., Dudziak D., Smith P., Ravetch J.V. FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. Proc. Natl. Acad. Sci. USA 2010, 107:19396-19401.
39. Otten M.A., van der Bij G.J., Verbeek S.J., Nimmerjahn F., Ravetch J.V., Beelen R.H., van de Winkel J.G., van Egmond M. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV. J. Immunol. 2008, 181:6829-6836.
40. Panizzi P., Swirski F.K., Figueiredo J.L., Waterman P., Sosnovik D.E., Aikawa E., Libby P., Pittet M., Weissleder R., Nahrendorf M. Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J. Am. Coll. Cardiol. 2010, 55:1629-1638.
41. Probst H.C., Tschannen K., Odermatt B., Schwendener R., Zinkernagel R.M., Van Den Broek M. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 2005, 141:398-404.
42. Ravetch J.V., Clynes R.A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 1998, 16:421-432.
43. Samuelsson A., Towers T.L., Ravetch J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001, 291:484-486.
44. Santiago-Raber M.L., Amano H., Amano E., Baudino L., Otani M., Lin Q., Nimmerjahn F., Verbeek J.S., Ravetch J.V., Takasaki Y., et al. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. Arthritis Rheum. 2009, 60:2408-2417.
45. Santiago-Raber M.L., Baudino L., Alvarez M., van Rooijen N., Nimmerjahn F., Izui S. TLR7/9-mediated monocytosis and maturation of Gr-1(hi) inflammatory monocytes towards Gr-1(lo) resting monocytes implicated in murine lupus. J. Autoimmun. 2011, 37:171-179.
46. Schmidt K.G., Rasmussen J.W. Kinetics and distribution in vivo of 111In-labelled autologous platelets in idiopathic thrombocytopenic purpura. Scand. J. Haematol. 1985, 34:47-56.
47. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 2006, 7:311-317.
48. Sprague C.C., Harrington W.J., Lange R.D., Shapleigh J.B. Platelet transfusions and the pathogenesis of idiopathic thrombocytopenic purpura. J. Am. Med. Assoc. 1952, 150:1193-1198.
49. Stratton J.R., Ballem P.J., Gernsheimer T., Cerqueira M., Slichter S.J. Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets. J. Nucl. Med. 1989, 30:629-637.
50. Syed S.N., Konrad S., Wiege K., Nieswandt B., Nimmerjahn F., Schmidt R.E., Gessner J.E. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. Eur. J. Immunol. 2009, 39:3343-3356.
51. Tacke F., Ginhoux F., Jakubzick C., van Rooijen N., Merad M., Randolph G.J. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 2006, 203:583-597.
52. Takai T. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2002, 2:580-592.
53. Takai T., Li M., Sylvestre D., Clynes R., Ravetch J.V. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994, 76:519-529.
54. Uchida J., Hamaguchi Y., Oliver J.A., Ravetch J.V., Poe J.C., Haas K.M., Tedder T.F. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. 2004, 199:1659-1669.
55. Weng W.K., Levy R. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J. Clin. Oncol. 2003, 21:3940-3947.
56. Weng W.K., Czerwinski D., Timmerman J., Hsu F.J., Levy R. Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype. J. Clin. Oncol. 2004, 22:4717-4724.
57. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., Leenen P.J., Liu Y.J., MacPherson G., Randolph G.J., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.